Related Experiment Video
Updated: Sep 13, 2025

3D Magnetic Stem Cell Aggregation and Bioreactor Maturation for Cartilage Regeneration
Published on: April 27, 2017
Magnetic nanoparticles influence the biological function of mesenchymal stem cells
Xinyue Li1, Sheng Qin2, Xiaoyun Liao3
1School of Life Sciences and Health, University of Health and Rehabilitation Sciences, Qingdao, 266113, Shandong, People's Republic of China.
Poly-L-lysine-modified magnetic nanoparticles (MNPs) enhance mesenchymal stem cell (MSC) migration and anti-inflammatory functions without cytotoxicity. This labeling offers new possibilities for clinical applications of MSC transplantation.
Area of Science:
- Biomedical Engineering
- Stem Cell Biology
- Nanotechnology
Background:
- Mesenchymal stem cells (MSCs) are utilized in transplantation for immune regulation and tissue repair.
- Magnetic nanoparticles (MNPs) offer potential for tracking transplanted MSCs.
- The impact of MNPs on MSC function requires investigation.
Purpose of the Study:
- To assess the effects of poly-L-lysine (PLL)-modified MNPs on MSC function.
- To evaluate the safety and efficacy of MNP-labeled MSCs for therapeutic applications.
Main Methods:
- MSCs were treated with PLL-modified MNPs (MSC-MNPs).
- Cell morphology, differentiation, proliferation, apoptosis, and cell cycle were analyzed.
- Migration capacity, cytokine expression, and cell surface markers were assessed.
- Co-culture experiments with activated astrocytes were performed.
Main Results:
- MNP treatment did not significantly affect MSC morphology, differentiation, proliferation, apoptosis, or cell cycle.
- MNPs significantly enhanced MSC migratory capacity.
- MNPs promoted anti-inflammatory cytokine expression and inhibited pro-inflammatory factors.
- MNP labeling increased specific MSC subpopulations (CD184+, CD106+, CD55+).
- MSC-MNPs promoted A1 to A2 astrocyte phenotypic transition.
Conclusions:
- MNP labeling is non-cytotoxic to MSCs.
- MNPs enhance MSC anti-inflammatory functions and migratory potential.
- MNP-labeled MSCs present promising avenues for clinical transplantation therapies.
More Related Videos
10:03Tracking Superparamagnetic Iron Oxide-labeled Mesenchymal Stem Cells using MRI after Intranasal Delivery in a Traumatic Brain Injury Murine Model
Published on: November 21, 2019
11:37Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting
Published on: June 18, 2018